Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Issues in sentinel node mapping in endometrial and vulva cancer

Prof Henry Kitchener – Manchester University, UK
Issues in sentinel node mapping in endometrial and vulva cancer ( Prof Henry Kitchener – Manchester University, UK )
31 Oct 2012

Complications in surgical approaches due to obesity

Dr Paola Gehrig – University of North Carolina, Chapel Hill, USA
 Complications in surgical approaches due to obesity ( Dr Paola Gehrig – University of North Carolina, Chapel Hill, USA )
31 Oct 2012

Radical hysterectomy of cervical cancer

Dr Shingo Fujii – Kitano Hospital, Osaka, Japan
Radical hysterectomy of cervical cancer ( Dr Shingo Fujii – Kitano Hospital, Osaka, Japan )
31 Oct 2012

Retrospective study on adjuvant therapy in vulva cancer

Prof Sven Mahner - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Retrospective study on adjuvant therapy in vulva cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf, Hamburg, Germany )
31 Oct 2012

Phase III HECTOR study: recurring platinum sensitive ovarian cancer

Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany
Phase III HECTOR study: recurring platinum sensitive ovarian cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany )
31 Oct 2012

GOG 209 study: optimal management of advanced endometrial cancer

Prof David Miller – University of Texas Southwestern Medical Centre, Dallas, USA
GOG 209 study: optimal management of advanced endometrial cancer ( Prof David Miller – University of Texas Southwestern Medical Centre, Dallas, USA )
31 Oct 2012

AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent ovarian cancer

Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway
AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent ovarian cancer ( Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway )
30 Oct 2012

The Cancer Genome Atlas and high grade serous ovarian cancer

Dr Andrew Berchuck – Duke University Medical Center, Durham, USA
The Cancer Genome Atlas and high grade serous ovarian cancer ( Dr Andrew Berchuck – Duke University Medical Center, Durham, USA )
30 Oct 2012

Benefits of nomogram versus staging in cervical cancer

Dr Stephen Polterauer – Medical University of Vienna, Austria
Benefits of nomogram versus staging in cervical cancer ( Dr Stephen Polterauer – Medical University of Vienna, Austria )
30 Oct 2012

Gestational trophoblastic disease tumours in high risk patients

Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK
Gestational trophoblastic disease tumours in high risk patients ( Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK )
30 Oct 2012

Late effects of treatment in gynaecological cancers

Dr Remi Nout – Leiden University Medical Center, Netherlands
Late effects of treatment in gynaecological cancers ( Dr Remi Nout – Leiden University Medical Center, Netherlands )
30 Oct 2012

Staging in endometrial cancer and sentinel node mapping

Dr Charles Levenback – MD Anderson Cancer Center, Houston, TX, USA
Staging in endometrial cancer and sentinel node mapping ( Dr Charles Levenback – MD Anderson Cancer Center, Houston, TX, USA )
30 Oct 2012